Effects of cilostazol on cerebral vasospasm after subarachnoid hemorrhage

Effects of cilostazol on cerebral vasospasm after subarachnoid hemorrhage - Effects of cilostazol on cerebral vasospasm

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011843

Enrollment

200

Registered

2013-12-01

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage

Interventions

cilostazol placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient over 20 years-old patient consented with informed consent from patient's or another person

Exclusion criteria

Exclusion criteria: patient did not consent to informed consent patient with drug allergy pregnant patient or patient of expectant pregnancy

Design outcomes

Primary

Measure	Time frame
change of cerebra vasospasm before and after treatment	—

Secondary

Measure	Time frame
functional prognosis (m-RS, GOS), evaluation of cerebral infarction with CT or MRI, frequency of adverse event	—

Countries

Japan

Contacts

Public ContactShiegru Tani

Tokyo Women's Medical University Medical Center East Department of Neurosurgery

stanine@dnh.twmu.ac.jp03-3810-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026